The $10 million gift from Andrew M. and Jane M. Bursky will advance cutting-edge research at the newly named Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs. Research at the center focuses on harnessing the immune system to fight cancer, infectious diseases, and autoimmune disorders.Read More
Science Market Update
Tags: Washington University in St. Louis, Washington University, Washington Univsersity St. Louis, Missouri, MO, Midwest Region, new research funding, cancer research, cancer therapy, Immune System, immune system research, infectious diseases
Dr. Stefan Sarafianos, a professor of Molecular Microbiology and Immunology at the University of Missouri, was recently awarded a research grant of $3 million from the National Institutes of Health to develop new drugs to treat Hepatitis B (HBV).Read More
The National Institutes of Health (NIH) recently launched a new network of institutions - called the Centers for Common Disease Genomics (CCDG) - which will study common conditions such as heart disease, stroke, diabetes, and autism to see how genetics and DNA contribute to the risk of these diseases. The McDonnell Genome Institute at Washington University in St. Louis is one of four institutions involved in this network and will be receiving $60 million over the next four years to study genomics and common diseases.Read More
Tags: Washington University St. Louis, Midwest, Missouri, WashU, heart disease, Diabetes, Autism, BioResearch Product Faire Event, MO, St Louis, NIH funding, 2016, Centers for Common Disease Genomics, stroke, CCDG
When it comes to fighting bacteria, it’s all about understanding the enemy. Bacteria are especially good at rapidly dividing; in fact, they are more efficient than cells at self-replication. Microbiologists at the Washington University, St. Louis decided to go straight to the root of the problem and find out how to turn bacteria into zombies that can’t reproduce.
The first step in shutting down bacterial replication was determining just why bacteria are so good at it, instead of just taking the fact for granted. Petra Levin (left), associate professor of biology at WUSTL, notes that “people spoke of the bacterial cell cycle as somehow magically coordinated even though there was no mechanism for doing so. Things just somehow worked out fine even though no control system had been identified.”
When it comes to creatively solving problems in biotechnology, time and time again nature takes the cake. In our recent history, we’ve seen the University of Minnesota use the kava root to prevent lung cancer and Michigan State University take cues from a mouse to develop new anesthetics. Now researchers at University of Washington, St. Louis are looking to nature to solve a problem where biotechnology is at its wit’s end: developing an effective antibiotic.
Washington University School of Medicine is constructing a new $75 million, 138,000 square-foot research building with a June 2015 target date for completion. The energy-efficient new research building at Washington University will feature state-of-the-art, highly flexible laboratory space where researchers will focus on the most prominent problems in human biology.
Tags: Washington University, Missouri, MO, St Louis, WashU, 2014, Washington University in St. Louis, St. Louis Bioresearch Product Faire Event, researcher invite, researchers invited, lab product expo
The most deadly and contagious strain of malaria actually isn’t found in Africa- it makes its home in Southeast Asia and South America. Plasmodium vivax, as the strain is known, has been a worldwide challenge to treat and prevent. However, thanks to groundbreaking lab work from Washington University in St. Louis, researchers are developing an understanding of how this form of malaria works and what can be done against it.
Determining the causes behind Alzheimer’s disease is a difficult task. Symptoms appear seemingly without provocation, and scientists have been so far unable to pinpoint a clear reason for their onset. Now bioresearchers at Washington University at St. Louis have found a possible explanation, in the form of a gene that regulates our internal clock.
Researchers at Washington University in St. Louis recently received a great deal of life science research funding for leukemia research. The National Cancer Institute, part of the National Institutes of Health (NIH), gave the university two grants totaling $26 million. The money will be given to leukemia researchers and physicians at Siteman Cancer Center at the Washington University School of Medicine, according to St. Louis American Local News.
Tags: Midwest, Washington University, Missouri, MO, BioResearch Product Faire Event, St Louis, NIH funding, 2013, WashU, NIH grant, NIH award, 2014, Washington University in St. Louis, St. Louis Bioresearch Product Faire Event